Isorem (Isosorbide Dinitrate)

Isosorbide dinitrate is metabolized to nitric oxide, which activates guanylate cyclase in vascular smooth muscle. This raises cyclic GMP levels, causing relaxation of veins and arteries, lowering preload and afterload, and ultimately decreasing myocardial oxygen consumption, which alleviates ischemic chest pain.

The specific dose of Isorem is determined by the prescribing clinician based on the patient’s clinical condition, severity of angina, and response to therapy. Dosage adjustments are made according to individual needs and tolerability, and patients should follow the prescriber’s instructions precisely.

Safety data for isosorbide dinitrate in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will evaluate the risk‑benefit profile before prescribing to pregnant or nursing women.

To request Isorem, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Isorem belongs to the nitrate class, which provides rapid vasodilation and is especially effective for acute angina relief. Compared with beta‑blockers or calcium‑channel blockers, nitrates act directly on vascular smooth muscle and are often used in combination therapy when monotherapy does not achieve adequate symptom control.

Isorem should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposing it to excessive heat or humidity, which could affect its stability.

Isorem is administered sublingually. The tablet is placed under the tongue and allowed to dissolve completely without swallowing. This route provides rapid absorption into the bloodstream, delivering quick relief of angina symptoms. Patients should remain seated or lying down after dosing to reduce the risk of dizziness.

Serious risks include severe hypotension, syncope, methemoglobinemia, and rare allergic reactions such as anaphylaxis. Patients experiencing sudden drops in blood pressure, fainting, or signs of an allergic response should seek immediate medical attention. Regular monitoring is essential, especially when combined with other vasodilators.

Isorem is contraindicated in patients with known hypersensitivity to isosorbide dinitrate or other nitrates, those with severe hypotension, and individuals who have recently used phosphodiesterase‑5 inhibitors (e.g., sildenafil) due to the risk of dangerous blood pressure reductions. Clinicians must assess each patient’s medical history before prescribing.